data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Dermata Therapeutics
(NASDAQ:DRMA)
$0.513
-0.1371[-21.09%]
At close: Jul 1
$0.53
0.0170[3.31%]
After Hours: 7:54PM EDT
Day High/Low0.51 - 0.58
52 Week High/Low0.44 - 6.95
Open / Close0.56 / 0.51
Float / Outstanding5.6M / 9.2M
Vol / Avg.1.4M / 598.3K
Mkt Cap4.7M
P/E-
50d Avg. Price0.75
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float5.6M

Dermata Therapeutics (NASDAQ:DRMA), Quotes and News Summary

Dermata Therapeutics (NASDAQ: DRMA)

Day High/Low0.51 - 0.58
52 Week High/Low0.44 - 6.95
Open / Close0.56 / 0.51
Float / Outstanding5.6M / 9.2M
Vol / Avg.1.4M / 598.3K
Mkt Cap4.7M
P/E-
50d Avg. Price0.75
Div / Yield-
Payout Ratio-
EPS-0.31
Total Float5.6M
Benzinga - 2 days ago
Benzinga - Jun 13, 2022, 9:02AM
Benzinga - May 17, 2022, 4:16PM
Benzinga - May 16, 2022, 4:08PM
Benzinga - Apr 25, 2022, 4:50PM
Benzinga - Apr 21, 2022, 9:05AM
Benzinga - Mar 28, 2022, 8:34AM
load more
Sector: Health Care.Industry: Pharmaceuticals
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-14
REV
Q1 2022Est.ActualSurprise
EPS-0.400-0.330 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Dermata Therapeutics Questions & Answers

Q
How do I buy Dermata Therapeutics (DRMA) stock?
A

You can purchase shares of Dermata Therapeutics (NASDAQ: DRMA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Dermata Therapeutics's (DRMA) competitors?
Q
What is the target price for Dermata Therapeutics (DRMA) stock?
A

The latest price target for Dermata Therapeutics (NASDAQ: DRMA) was reported by Brookline Capital on Tuesday, September 21, 2021. The analyst firm set a price target for 14.00 expecting DRMA to rise to within 12 months (a possible 2629.04% upside). 2 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Dermata Therapeutics (DRMA)?
A

The stock price for Dermata Therapeutics (NASDAQ: DRMA) is $0.513 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Dermata Therapeutics (DRMA) pay a dividend?
A

There are no upcoming dividends for Dermata Therapeutics.

Q
When is Dermata Therapeutics (NASDAQ:DRMA) reporting earnings?
A

Dermata Therapeutics’s Q2 earnings are confirmed for Sunday, August 14, 2022.

Q
Is Dermata Therapeutics (DRMA) going to split?
A

There is no upcoming split for Dermata Therapeutics.

Q
What sector and industry does Dermata Therapeutics (DRMA) operate in?
A

Dermata Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.